SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-002343
Filing Date
2023-11-13
Accepted
2023-11-13 06:51:00
Documents
60
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lptx-20230930x10q.htm   iXBRL 10-Q 1550079
2 EX-3.1 lptx-20230930xex3d1.htm EX-3.1 16271
3 EX-3.2 lptx-20230930xex3d2.htm EX-3.2 16299
4 EX-31.1 lptx-20230930xex31d1.htm EX-31.1 11751
5 EX-32.1 lptx-20230930xex32d1.htm EX-32.1 6973
  Complete submission text file 0001410578-23-002343.txt   6128134

Data Files

Seq Description Document Type Size
6 EX-101.SCH lptx-20230930.xsd EX-101.SCH 42904
7 EX-101.CAL lptx-20230930_cal.xml EX-101.CAL 36211
8 EX-101.DEF lptx-20230930_def.xml EX-101.DEF 157754
9 EX-101.LAB lptx-20230930_lab.xml EX-101.LAB 394037
10 EX-101.PRE lptx-20230930_pre.xml EX-101.PRE 274951
54 EXTRACTED XBRL INSTANCE DOCUMENT lptx-20230930x10q_htm.xml XML 990609
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37990 | Film No.: 231394960
SIC: 2834 Pharmaceutical Preparations